Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of T lymphocyte for producing medicament

A lymphocyte and application technology, applied in the pharmaceutical field, can solve the problems of reducing the quality of life of patients, unable to cure AIDS, drug side effects, etc., and achieve the effects of no toxic side effects, strong pharmacological effects, and prolonging life.

Inactive Publication Date: 2008-05-21
于庆文
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The currently clinically used drugs for the treatment of AIDS cannot cure AIDS. They only try to prolong the life of the patient, but the side effects of the drug reduce the quality of life of the patient in the short survival period.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0006] Embodiments of the present invention are described below.

[0007] Through conventional blood separation methods, obtain the drug preparation containing human immune cells, that is, T lymphocyte plasma; AIDS patients can take the aforementioned T lymphocyte plasma drug orally on an empty stomach, and can eat after 3-5 hours; the retention time of the drug in the gastrointestinal tract Here, HIV enters into T lymphocytes, because the time required for HIV to multiply in T lymphocytes is longer than the time that T lymphocytes stay in the digestive system of the human body, when HIV has not multiplied, it is combined with T lymphocyte drugs Excreted from the body to complete the purpose of controlling and reducing the number of HIV and treating diseases. The separated blood produced by the medicine can be human blood or animal blood which has no rejection reaction with the human body.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the usage of T-lymphocytes in blood in the pharmaceutical field; the drug obtains the plasma drug containing human immune cells, that is, T-lymphocytes, by separating blood cells, the invention has the effects of effectively reducing HIV virus in the bodies of patients, avoiding the great breeding of HIV virus in the body, prolonging the lives of patients, improving the quality of life and having simple administration and no side effects.

Description

technical field [0001] The present invention relates to the use of T lymphocytes in blood, in particular to the use in the field of pharmacy. Background technique [0002] T lymphocytes are cells that exist in the blood and have immune functions. Current medical research proves that the survival of HIV in the human body is just attached to T lymphocytes, and survives and reproduces in them, fundamentally destroying the immune ability of the human body and causing human death. The current clinically used drugs for treating AIDS cannot cure AIDS, and only try to prolong the life of the patient, but the side effects of the drug reduce the quality of life of the patient in the short survival period. Contents of the invention [0003] The purpose of the present invention is to provide a new application of T lymphocytes, that is, a new application in pharmacy for the treatment of AIDS, aiming at the problems existing in the above-mentioned prior art. [0004] In fact, this pro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/14A61P31/18A61K35/17
Inventor 于庆文
Owner 于庆文
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com